Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms |
Target |
Mechanism M1 receptor agonists(Muscarinic acetylcholine receptor M1 agonists), PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diagnostic agents | Preclinical | US | 11 Apr 2018 | |
Schizoaffective disorder | Discovery | US | 20 Apr 2021 | |
Schizophrenia | Discovery | US | 20 Apr 2021 |
Not Applicable | - | - | (11C-LSN3172176) | unrnuotrdw(zhevvjuxvo) = uwumncbyim oufwobgony (vfusnvecjo, 3) View more | - | 24 May 2017 |